Literature DB >> 2830405

High metalloproteinase inhibitor content of human cirrhosis and its possible conference of metastasis resistance.

S H Barsky1, R Gopalakrishna.   

Abstract

Human cirrhotic livers exhibited a strong resistance to metastasis and demonstrated high levels of both soluble and 3 M NaCl extractable metalloproteinase inhibitor(s) directed against tumor type I and type IV collagenases. This inhibitory activity was detected in human cirrhosis from diverse causes, including alpha-1-antitrypsin deficiency, alcoholic liver disease, postviral hepatitis, and biliary cirrhosis, but was nearly undetectable in normal liver. The inhibitory activity was able to be purified by carboxymethyl cellulose chromatography and gel filtration, had a molecular weight of approximately 40,000, and was relatively heat stable. Such metalloproteinase inhibitory activity was also present in conditioned media of human myofibroblast primary cultures obtained from cirrhotic liver explants but absent in conditioned media of primary normal liver explants. Purified fractions of the metalloproteinase inhibitor activity obtained from both myofibroblast conditioned media and extracts of cirrhotic liver blocked invasion but not attachment of MCF-7 cells on human amnion in vitro. The results further support the role of myofibroblasts in inhibiting tumor invasion and metastasis and provide one possible mechanism by which cirrhotic livers resist metastasis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2830405     DOI: 10.1093/jnci/80.2.102

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  3 in total

1.  Immunohistochemical study on tissue inhibitors of metalloproteinases in normal and pathological human livers.

Authors:  Y Fukuda; M Imoto; Y Koyama; Y Miyazawa; I Nakano; M Hattori; F Urano; S Kodama; K Iwata; T Hayakawa
Journal:  Gastroenterol Jpn       Date:  1991-02

2.  Oncologic and surgical outcomes in colorectal cancer patients with liver cirrhosis: A propensity-matched study.

Authors:  Eon Chul Han; Seung-Bum Ryoo; Ji Won Park; Jin Wook Yi; Heung-Kwon Oh; Eun Kyung Choe; Heon-Kyun Ha; Byung Kwan Park; Sang Hui Moon; Seung-Yong Jeong; Kyu Joo Park
Journal:  PLoS One       Date:  2017-06-06       Impact factor: 3.240

Review 3.  The Effect of Diffuse Liver Diseases on the Occurrence of Liver Metastases in Cancer Patients: A Systematic Review and Meta-Analysis.

Authors:  Filippo Monelli; Giulia Besutti; Olivera Djuric; Laura Bonvicini; Roberto Farì; Stefano Bonfatti; Guido Ligabue; Maria Chiara Bassi; Angela Damato; Candida Bonelli; Carmine Pinto; Pierpaolo Pattacini; Paolo Giorgi Rossi
Journal:  Cancers (Basel)       Date:  2021-05-07       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.